| 12378266 |
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders |
Joseph Araujo |
2025-08-05 |
|
| 12054505 |
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders |
Joseph Araujo |
2024-08-06 |
|
| 12054504 |
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders |
Joseph Araujo |
2024-08-06 |
|
| 11597738 |
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders |
Joseph Araujo |
2023-03-07 |
|
| 11591353 |
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders |
Joseph Araujo |
2023-02-28 |
|
| 11453689 |
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders |
Joseph Araujo |
2022-09-27 |
|
| 11427604 |
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders |
Joseph Araujo |
2022-08-30 |
|
| 10696670 |
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins |
Peter Dove |
2020-06-30 |
$8,462,000 |
| 10604476 |
Fluorinated amide derivatives and their uses as therapeutic agents |
— |
2020-03-31 |
$4,387,000 |
| 10428030 |
Heterocycle derivatives and their use for the treatment of CNS disorders |
— |
2019-10-01 |
$209,000 |
| 10259809 |
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins |
Peter Dove |
2019-04-16 |
$280,000 |
| 9441012 |
Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors |
Peter Dove |
2016-09-13 |
$1,535,000 |
| 8450336 |
Use of D-serine derivatives for the treatment of anxiety disorders |
Guy Higgins, Methvin Isaac |
2013-05-28 |
$17,292,000 |
| 8377940 |
Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842 |
Joshua Clayton, Ian Egle, James Empfield, James Folmer, Methvin Isaac +1 more |
2013-02-19 |
$9,998,000 |
| 8377939 |
Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842 |
Joshua Clayton, Ian Egle, James Empfield, James Folmer, Methvin Isaac +1 more |
2013-02-19 |
$9,998,000 |
| 8153638 |
Metabotropic glutamate-receptor-potentiating isoindolones |
Bradford C. Van Wagenen, Radhakrishnan Ukkiramapandian, Joshua Clayton, Ian Egle, James Empfield +5 more |
2012-04-10 |
$4,704,000 |
| 8148394 |
Azaindoles having serotonin receptor affinity |
Louise Edwards, Ashok Tehim, Tao Xin |
2012-04-03 |
$3,496,000 |
| 7968570 |
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
Joshua Clayton, Fupeng Ma, Bradford C. Van Wagenen, Radhakrishnan Ukkiramapandian, Ian Egle +5 more |
2011-06-28 |
$12,615,000 |
| 7960422 |
Pharmaceutically active compounds containing tetrazolyl and triazolyl rings |
Erwan Arzel, Louise Edwards, Methvin Isaac, Donald McLeod, Tao Xin |
2011-06-14 |
$4,075,000 |
| 7935703 |
Piperazines and piperidines as Mglur5 potentiators |
Methvin Isaac, Jalaj Arora, Dean Brown |
2011-05-03 |
$28,363,000 |
| 7902401 |
Fluorinated compounds |
Guy Higgins, Methvin Issac, Tao Xin |
2011-03-08 |
$6,776,000 |
| 7868008 |
Substituted isoindolones and their use as metabotropic glutamate receptor potentiators |
Bradford C. Van Wagenen, Radhakrishnan Ukkiramapandian, Joshua Clayton, Ian Egle, James Empfield +5 more |
2011-01-11 |
$8,586,000 |
| 7816354 |
Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
Methvin Isaac, Ian Egle, Fupeng Ma, Babu Joseph, Joshua Clayton +1 more |
2010-10-19 |
$4,428,000 |
| 7807706 |
Metabotropic glutamate-receptor-potentiating isoindolones |
Bradford C. Van Wagenen, Radhakrishnan Ukkiramapandian, Joshua Clayton, Ian Egle, James Empfield +5 more |
2010-10-05 |
$13,377,000 |
| 7799792 |
Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841 |
Joshua Clayton, Ian Egle, James Empfield, James Folmer, Methvin Isaac +1 more |
2010-09-21 |
$6,963,000 |
